Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.39K Hold
18
﹤0.01% 99
2026
Q1
$6.3K Hold
18
﹤0.01% 106
2025
Q4
$5.94K Hold
18
﹤0.01% 107
2025
Q3
$5.42K Hold
18
﹤0.01% 122
2025
Q2
$5.31K Sell
18
-7
-28% -$1.98K ﹤0.01% 120
2025
Q1
$7.23K Buy
25
+7
+39% +$2.07K ﹤0.01% 107
2024
Q4
$5K Hold
18
﹤0.01% 110
2024
Q3
$5.85K Hold
18
﹤0.01% 106
2024
Q2
$5.96K Hold
18
﹤0.01% 110
2024
Q1
$4.75K Hold
18
﹤0.01% 144
2023
Q4
$5.46K Buy
+18
New +$4.9K ﹤0.01% 142

Other funds holding AMGN

Bear Mountain Capital's AMGN Position: Q2 2026 in Review

Bear Mountain Capital held its Amgen (AMGN) position steady in Q2 2026 at 18 shares worth $6.39K. The position accounts for ﹤0.01% of the portfolio, ranked #99.

Bear Mountain Capital first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $7.23K in Q1 2025. 1,255 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Bear Mountain Capital held 18 shares of Amgen worth $6.39K as of Q2 2026.
  • Bear Mountain Capital left its Amgen share count unchanged in Q2 2026.
  • Amgen made up ﹤0.01% of Bear Mountain Capital's portfolio in Q2 2026, its #99 holding.
  • Bear Mountain Capital first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • Bear Mountain Capital's Amgen position peaked at $7.23K in Q1 2025.
  • 1,255 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Bear Mountain Capital's 13F filing for Q2 2026, filed 20 Jul 2026.